The effect of an intervention comprising a coordinated and integrated medicine management service (Home Medicines Review (HMR)) provided for patients in primary care with osteoporosis (OP) and Minimal Trauma Fracture (MTF)

Not Applicable

• Conditions: Osteoporosis.; Minimal Trauma Fracture.; Polypharmacy; Falls; Musculoskeletal - Osteoporosis; Musculoskeletal - Other muscular and skeletal disorders; Injuries and Accidents - Fractures

• Registration Number: ACTRN12622000261718
• Lead Sponsor: niversity of Sydney

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-02-14
• Last Update Posted: 21 February 2022

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 1092

Inclusion Criteria

Patients over 65 years, taking more than 5 medicines with a history of OP who have had a MTF and reside in a domiciliary dwelling.

Exclusion Criteria

Patients that are unable to consent or are receiving treatment for palliative care.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in participant’s Drug Burden Index (DBI). <br><br>The drug burden is a measure of burden obtained from anticholinergic and sedative medicine load calculated via participant medication lists collected via community pharmacy records and validated through PBS records (obtained via linked data - NSW Centre for Health Record Linkage (CHEREL) and the Centre for Victorian Data Linkage (CVDL). [DBI will be calculated at baseline, 3 months, and 12 months (primary time-point) post recruitment via retrospectively received medication-list data.]